During initial assessment of individuals with schizophrenia and related disorders (schizophrenia spectrum disorders [SSDs]), clinicians tend to pay greater attention to psychotic symptoms than mood symptoms, including depression. Depression is reported to influence the course of SSDs, but not much is known about the risk factors for depression in SSDs. In the present study, we examined clinical predictors of depression in SSDs.
Methods
The sample included 71 patients with SSDs followed in a modified Assertive Community Treatment program, the Community Support Network of Springfield, Illinois. The study design was naturalistic, prospective, and longitudinal (mean follow-up = 8.3 years; SD = 7.3). The GENMOD procedure appropriate for repeated measures analysis with dichotomous outcome variables followed longitudinally was computed.
Results
Rates of depression ranged from 18% to 41% over the differing assessment periods. Schizophrenia and schizoaffective disorder did not vary by depression rate. Depression independent of SSD diagnosis was associated with greater hospitalization rates. Clinical variables predicting depression were auditory hallucinations, delusions, poor insight, and poor judgment.
Conclusions
Psychotic symptoms in the course of SSDs are risk factors for depression. As a consequence, the mental status examination of patients with SSDs with active psychosis should include assessment of mood changes. Further research is warranted to determine if treatment of depression among patients with SSDs may reduce their rates of hospitalization.
Get full access to this article
View all access options for this article.
References
1.
PiniS, De QueirozV, Dell'OssoL, . Cross-sectional similarities and differences between schizophrenia, schizoaffective disorder and mania or mixed mania with mood-incongruent psychotic features. Eur Psychiatry. 2004;19:8–14.
2.
TwamleyEW, HuaJP, BurtonCZ, . Effects of COMT on cognitive ability and functional capacity of individuals with schizophrenia. Schizophr Res. 2014;159:114–117.
3.
BirchwoodM, IqbalZ, ChadwickP, . Cognitive approach to depression and suicidal thinking in psychosis: I. Ontogeny of post-psychotic depression. Br J Psychiatry. 2000;177:516–521.
4.
HirschSR, JolleyAG.The dysphoric syndrome in schizophrenia and its implications for relapse. Br J Psychiatry Suppl. 1989;5:46–50.
5.
HorK, TaylorM.Suicide and schizophrenia: a systematic review of rates and risk factors. J Psychopharmacol. 2010;24:81–90.
6.
KoreenAR, SirisSG, ChakosM, . Depression in first-episode schizophrenia. Am J Psychiatry. 1993;150:1643–1648.
7.
SchennachR, RiedelM, ObermeierM, . What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder? Eur Psychiatry. 2015;30:43–50.
8.
CoryellW, ZimmermanM.Heritability of schizophrenia and schizoaffective disorder: a family study. Arch Gen Psychiatry. 1988;45:323–327.
9.
PerkinsDO, JeffriesCD, JarskogLF, . microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol. 2007;8:R27.
10.
KirkpatrickB.Developing concepts in negative symptoms: primary vs secondary and apathy vs expressions. J Clin Psychiatry. 2014;75:(suppl 1)3–7.
11.
KirkpatrickB, FentonWS, CarpenterWTJr, . The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull. 2006;32:214–219.
12.
MulhollandC, CooperS.The symptom of depression in schizophrenia and its management. Advances in Psychiatric Treatment. 2000;6:169–177.
13.
PeraltaV, CuestaMJ.Exploring the borders of schizophrenia spectrum: a categorical and dimensional approach. J Affect Disord. 2008;108:71–86.
14.
SirisSG.Suicide and schizophrenia. J Psychopharmacol. 2001;15:127–135.
15.
SmithB, FowlerDG, FreemanD, . Emotion and psychosis: links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations. Schizophr Res. 2006;86:181–188.
16.
HodgkinsonCA, GoldmanD, JaegerJ, . Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet. 2004;75:862–872.
17.
Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
18.
Diagnostic and statistical manual of mental disorders, 5th ed. Washington, DC: American Psychiatric Association; 2013.
19.
AbramsDJ, RojasDC, ArciniegasDB.Is schizoaffective disorder a distinct categorical diagnosis? A critical review of the literature. Neuropsychiatr Dis Treat. 2008;4:1089–1109.
20.
PearlsonGD, FolleyBS.Schizophrenia, psychiatric genetics, and Darwinian psychiatry: an evolutionary framework. Schizophr Bull. 2008;34:722–733.
21.
TandonR, JibsonM.Negative symptoms of schizophrenia: how to treat them most effectively. Current Psychiatry. 2002;1:36–42.
22.
RoyA, ThompsonR, KennedyS.Depression in chronic schizophrenia. Br J Psychiatry. 1983;142:465–470.
23.
ConleyRR, Ascher-SvanumH, ZhuB, . The burden of depressive symptoms in the long-term treatment of patients with schizophrenia. Schizophr Res. 2007;90:186–197.
HarrowM, JobeTH.Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multifollow-up study. J Nerv Ment Dis. 2007;195:406–414.
26.
OlivaresJM, SermonJ, HemelsM, . Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review. Ann Gen Psychiatry. 2013;12:32.
27.
FolsomDP, HawthorneW, LindamerL, . Prevalence and risk factors for homelessness and utilization of mental health services among 10,340 patients with serious mental illness in a large public mental health system. Am J Psychiatry. 2005;162:370–376.
28.
AwadAG, VorugantiLN.The burden of schizophrenia on caregivers: a review. Pharmacoeconomics. 2008; 26:149–162.
29.
Rössler W, SalizeHJ, van OsJ, . Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol. 2005;15:399–409.
30.
WuEQ, BirnbaumHG, ShiL, . The economic burden of schizophrenia in the United States in 2002. J Clin Psychiatry.2005;66:1122–1129.
31.
LincolnTM, LüllmannE, RiefW.Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review. Schizophr Bull. 2007;33:1324–1342.
32.
StaringAB, Van der GaagM, Van den BergeM, . Stigma moderates the associations of insight with depressed mood, low self-esteem and low quality of life in patients with schizophrenia spectrum disorders. Schizophr Res. 2009;115:363–369.
33.
WittmannD, KeshavanM.Grief and mourning in schizophrenia. Psychiatry. 2007;70:154–166.
34.
SAS version 9.3. Cary, NC: SAS Institute; 2011.
35.
BirchwoodM, IqbalZ, UpthegroveR.Psychological pathways to depression in schizophrenia: studies in acute psychosis, post psychotic depression and auditory hallucinations. Eur Arch Psychiatry Clin Neurosci. 2005;255:202–212.
36.
HäfnerH, MaurerK, TrendlerG, . Schizophrenia and depression: challenging the paradigm of two separate diseases—a controlled study of schizophrenia, depression and healthy controls. Schizophr Res. 2005;77:11–24.
37.
WeiserW, ReichenbergA, RabinowitzJ, . Association between nonpsychotic psychiatric diagnosis in adolescent males and subsequent onset of schizophrenia. Arch Gen Psychiatry. 2001;58:959–964.
38.
SimK, MahendranR, SirisSG, . Subjective quality of life in first episode schizophrenia spectrum disorders with comorbid depression. Psychiatry Res. 2004;129:141–147.
39.
ZisookS, NyerM, KasckowJ, . Depressive symptom patterns in patients with chronic schizophrenia and subsyndromal depression. Schizophr Res. 2006;86:226–233.
HäfnerH, MaurerK, TrendlerG, . The early course of schizophrenia and depression. Eur Arch Psychiatry Clin Neurosci. 2005;255:167–173.
42.
MueserKT, BellackAS, BradyEU.Hallucinations in schizophrenia. Acta Psychiatr Scand. 1990;82:26–29.
43.
OsatukeK, CieslaJ, KasckowJW, . Insight in schizophrenia: a review of etiological models and supporting research. Compr Psychiatry. 2008;49:70–77.
44.
SaveanuRV, NemeroffCB.Etiology of depression: genetics and environmental factors. Psychiatr Clin North Am. 2012;35:51–71.
45.
Hasson-OhayonI, KravetzS, MeirT, . Insight into severe mental illness, hope, and quality of life of persons with schizophrenia and schizoaffective disorders. Psychiatry Res. 2009;167:231–238.
46.
PerkinsDO.Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry. 2002;63:1121–1128.
47.
PerkinsDO, JohnsonJL, HamerRM, ; HGDH Research Group. Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode. Schizophr Res. 2006;83:53–63.
48.
OlfsonM, MechanicD, HansellS, . Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatr Serv. 2000;51:216–222.
49.
WeidenPJ, KozmaC, GroggA, . Partial compliance and risk of hospitalization among California Medicaid patients with schizophrenia. Psychiatr Serv. 2004;55:886–891.
50.
MintzAR, DobsonKS, RomneyDM.Insight in schizophrenia: a meta-analysis. Schizophr Res. 2004;61:75–88.
51.
MulhollandC, LynchG, KingDJ, . A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia. J Psychopharmacol. 2003;17:107–112.
52.
KumarS, KodelaS, DetweilerJD, . Bupropion-induced psychosis: folklore or a fact? A systematic review of the literature. Gen Hosp Psychiatry. 2011;33:612–617.
53.
NakanishiS, KunugiH, TakahashiT.Efficacy of milnacipran for depressive symptoms in schizophrenia spectrum disorders. Psychiatry Clin Neurosci. 2004;58:226–227.
54.
JacksonC, BernardM, BirchwoodM.The efficacy of psychotherapy in reducing post-psychotic trauma. Epidemiol Psychiatr Sci. 2011;20:127–131.
